Skip to main
CI

Cigna (CI) Stock Forecast & Price Target

Cigna (CI) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 29%
Buy 47%
Hold 24%
Sell 0%
Strong Sell 0%

Bulls say

Cigna Group is well-positioned for growth and has a positive outlook due to its strong performance in the first quarter of 2026, driven by solid specialty volume growth and continued mix shift towards higher-margin products. The company's decision to exit the Exchange business in 2027 and strategic review of EviCore show its commitment to focusing on core growth opportunities. Additionally, Cigna's strong retention and early new business wins in the 2027 Pharmacy Benefit selling season bode well for future growth. Overall, the company's aggressive share repurchase activity and expansion of its Evernorth services should support low-teens EPS growth in the near term. Risks include potential impacts from regulatory changes on rebate economics and a protracted economic downturn.

Bears say

Cigna Group is facing considerable risks, including potential government headwinds and low utilization due to contractual arrangements, which could negatively impact its growth and profitability in the short term. In addition, delays or failures in successfully integrating recent acquisitions, such as Express Scripts and VillageMD, could also hinder Cigna's long-term growth potential. Although the company has a strong focus on improving access, cost and quality of care, uncertainties surrounding political and regulatory issues pose potential risks to its sustainability efforts. These risks, along with Cigna's current valuation at a discount to its historical average, justify a negative outlook on the stock.

Cigna (CI) has been analyzed by 17 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 47% recommend Buy, 24% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cigna and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cigna (CI) Forecast

Analysts have given Cigna (CI) a Buy based on their latest research and market trends.

According to 17 analysts, Cigna (CI) has a Buy consensus rating as of Sep 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $342.88, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $342.88, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cigna (CI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.